Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind placebo-controlled trial

BACKGROUND: Antiretroviral therapy (ART) reduces the risk of tuberculosis, but the incidence still exceeds that in HIV-uninfected people. Isoniazid preventive therapy (IPT), which decreases the risk of tuberculosis in people not on ART, may offer additional protection. METHODS: Pragmatic randomized...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet
Main Authors: Rangaka, Molebogeng X, Wilkinson, Robert J, Boulle, Andrew, Glynn, Judith R, Fielding, Katherine, van Cutsem, Gilles, Wilkinson, Katalin A, Goliath, Rene, Mathee, Shaheed, Goemaere, Eric, Maartens, Gary
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4233253/
https://ncbi.nlm.nih.gov/pubmed/24835842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(14)60162-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados